Announcements

We are thrilled to share the updated Exceptional Reviewers List 2024. This program was designed to recognize scholars who have consistently delivered exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, Cancers (ISSN: 2072-6694) recognizes the significant role that our reviewers play in maintaining the quality and integrity of the articles that we publish. According to surveys conducted in 2023, 91% of our authors rate the peer-review process as good or excellent, which is thanks to our pool of excellent reviewers.

We wish to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist Cancers’ peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback and contributing to academic rigor, are truly commendable.

The Exceptional Reviewers List was introduced in April 2024. Each quarter, we will be selecting a group of outstanding reviewers and introduce them here.

Q1

Name: Dr. Muhammad Kibriya
Affiliation: Institute for Population and Precision Health (IPPH), Biological Sciences Division, University of Chicago, Chicago, IL, USA
Interests: colorectal carcinoma; microsatellite instability; cytogenetics; molecular genomics; GWAS; copy number change; telomere; methylation; liquid biopsy

Name: Dr. Matthias Nees
Affiliation: Department of Biochemistry and Molecular Biology, Medical University in Lublin, Lublin, Poland
Interests: organotypic culture; tumor/stroma interactions; 3D models; extracellular matrix (ECM); tumour microenvironment (TME); epithelial-to-mesenchymal transition (EMT); automated image analyses; phenotypic screening; personalized medicine

Name: Dr. Laura Casalino
Affiliation: Institute of Genetics and Biophysics “Adriano Buzzati Traverso”, Consiglio Nazionale dele Ricerche (CNR), Naples, Italy
Interests: cell differentiation; development; stem cells; transcription factors; epigenetics

Name: Dr. Antonella Argentiero
Affiliation: Medical Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Bari, Italy
Interests: pancreatic cancer; pancreatic ductal adenocarcinoma; tumor microenvironment

Name: Dr. John T. Lucas, Jr.
Affiliation: St. Jude Children’s Research Hospital, Memphis, TN, USA
Interests: neuroblastoma; high grade glioma; proteomics; clinical trial design/methodology

Q2:

Name: Prof. Dr. Laura Salter Kubatko
Affiliation: Department of Evolution, Ecology and Organismal Biology, The Ohio State University, Columbus, OH 43210, USA
Interests: statistical genetics; phylogenetics; population genetics; computational biology; statistical education

Name: Dr. Bethany N. Smith
Affiliation: Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
Interests: role of androgen signaling in prostate cancer; microenvironment; cancer metabolism

Name: Prof. Dr. Antonio Maccio
Affiliation: Department of Gynecologic Oncology, ARNAS G. Brotzu and Department of Surgical Sciences, University of Cagliari, Cagliari, Italy
Interests: ovarian cancer; laparoscopic surgery; immune system and immunotherapy; inflammation; macrophages; cytokines; cancer cachexia; cancer-related anemia

Name: Dr. Theo Kantidakis
Affiliation: Aston Medical School, College of Health and Life Sciences, Aston University, Birmingham B4 7ET, UK
Interests: tRNA; kmt2d; mll2; chromatin; RNA Polymerase III; genomic instability; RNA Polymerase II; cancer; rna-seq; aminoacyl-trna synthetase; mll3; KMT2C

Name: Dr. Tariq Bhat
Affiliation: Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA
Interests: immune dysfunction in infections and cancer; prostate cancer; bladder cancer; microbial dysbiosis in cancer; tumor Immunology; immunometabolism and antitumor immunity

Q3:

Name: Dr. Luca Fagnocchi
Affiliation: Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA
Interests: bioinformatics; epigenetics; molecular biology; gene regulation

Name: Dr. Mohammed L. Abba
Affiliation:Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
Interests: oncology; translational cancer research; microRNA

Name: Dr. Karin Wallander
Affiliation: Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
Interests: sarcoma; genomics; transcriptomics

Name: Dr. Josep Baulida
Affiliation: Hospital del Mar Research Institute (IMIM), Barcelona, Spain
Interests: molecular mechanisms that regulate pro-metastatic tumor stroma; transcriptomics; snai1 gene

Name: Dr. Paolo Emidio Costantini 
Affiliation: Dipartimento di Farmacia e Biotecnologie, Alma Mater Studiorum, Università di Bologna, Via Francesco Selmi 3, Bologna, 40126, Italy
Interests: microbiology; molecular biology

Q4:

Name: Dr. Amit K. Maiti
Affiliation: Department of Genetics and Genomics, Mydnavar, 2645 Somerset Boulevard, Troy, MI 48084, USA
Interests: lymphomas; radiation oncology

Name: Dr. Michael S. Jackson
Affiliation: Newcastle University, United Kingdom, Institute of Genetic Medicine, Newcastle, United Kingdom
Interests: circular RNA; genome instability; cancer

Name: Dr. Marta Maria Falcão Estrada
Affiliation: Champalimaud Centre of the Unknown, Champalimaud Foundation, 1400-038 Lisbon, Portugal
Interests: breast cancer; ovarian cancer; translational research in oncology; in vitro/ex vivo 3D complex models; zebrafish xenograft models

Name: Dr. Jeremie Vitte
Affiliation: Department of Head and Neck Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA
Interests: tumor predisposition syndromes; neuro-oncology; neurofibromatosis type 2; schwannomatosis; rhabdoid tumor predisposition syndrome; pre-clinical research

Name: Dr. Francesco Bianconi
Affiliation: Department of Engineering, Università degli Studi di Perugia, Via Goffredo Duranti 93–06125 Perugia (PG), Italy
Interests: artificial intelligence; computational imaging; computer vision; image processing; medical image analysis; radiomics
“Reviewing papers helps me to keep up with the latest advancements in my field.”